Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001326024 | SCV001517036 | uncertain significance | Hypertrophic cardiomyopathy | 2020-04-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). This variant has not been reported in the literature in individuals with TNNI3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with arginine at codon 187 of the TNNI3 protein (p.Glu187Arg). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and arginine |